$BSX
BOSTON SCIENTIFIC CORP

2024 Q2 Form 10-Q Financial Statement

#000088572524000046 Filed on May 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $4.120B $3.856B
YoY Change 14.48% 13.78%
Cost Of Revenue $1.279B $1.209B
YoY Change 21.81% 15.03%
Gross Profit $2.841B $2.648B
YoY Change 11.46% 13.26%
Gross Profit Margin 68.96% 68.67%
Selling, General & Admin $1.446B $1.364B
YoY Change 6.79% 12.26%
% of Gross Profit 50.9% 51.51%
Research & Development $383.0M $366.0M
YoY Change 6.69% 8.61%
% of Gross Profit 13.48% 13.82%
Depreciation & Amortization $213.0M $304.0M
YoY Change -28.52% 49.75%
% of Gross Profit 7.5% 11.48%
Operating Expenses $2.044B $1.973B
YoY Change 5.25% 11.72%
Operating Profit $797.0M $675.0M
YoY Change 31.3% 18.01%
Interest Expense -$77.00M $69.00M
YoY Change -2.53% -206.15%
% of Operating Profit -9.66% 10.22%
Other Income/Expense, Net -$23.00M -$67.00M
YoY Change 155.56% 55.81%
Pretax Income $420.0M $608.0M
YoY Change -1.41% 36.94%
Income Tax $98.00M $115.0M
% Of Pretax Income 23.33% 18.91%
Net Earnings $324.0M $493.0M
YoY Change 24.14% 64.33%
Net Earnings / Revenue 7.86% 12.79%
Basic Earnings Per Share $0.22 $0.34
Diluted Earnings Per Share $0.22 $0.33
COMMON SHARES
Basic Shares Outstanding 1.470B shares 1.467B shares
Diluted Shares Outstanding 1.484B shares 1.482B shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.913B $2.329B
YoY Change 583.8% 308.6%
Cash & Equivalents $2.913B $2.329B
Short-Term Investments
Other Short-Term Assets $756.0M $671.0M
YoY Change -29.74% -5.63%
Inventory $2.608B $2.561B
Prepaid Expenses
Receivables $2.400B $2.304B
Other Receivables $0.00 $0.00
Total Short-Term Assets $8.991B $8.185B
YoY Change 52.75% 43.5%
LONG-TERM ASSETS
Property, Plant & Equipment $2.951B $2.897B
YoY Change -0.94% 16.91%
Goodwill $14.40B $14.36B
YoY Change 5.4% 8.23%
Intangibles $5.417B $5.839B
YoY Change -10.65% -3.65%
Long-Term Investments $207.0M $211.0M
YoY Change -67.04% 27.11%
Other Assets $1.551B $1.596B
YoY Change -64.64% 7.69%
Total Long-Term Assets $28.12B $28.48B
YoY Change 1.45% 4.77%
TOTAL ASSETS
Total Short-Term Assets $8.991B $8.185B
Total Long-Term Assets $28.12B $28.48B
Total Assets $37.11B $36.67B
YoY Change 10.44% 11.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $906.0M $921.0M
YoY Change 0.78% 6.11%
Accrued Expenses $2.320B $2.083B
YoY Change 18.67% 8.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.580B $1.085B
YoY Change 182.65% 112.75%
Total Short-Term Liabilities $5.576B $4.916B
YoY Change 22.23% 20.4%
LONG-TERM LIABILITIES
Long-Term Debt $8.991B $9.534B
YoY Change 5.85% 12.23%
Other Long-Term Liabilities $1.800B $1.919B
YoY Change -6.49% -3.81%
Total Long-Term Liabilities $1.800B $1.919B
YoY Change -82.72% -3.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.576B $4.916B
Total Long-Term Liabilities $1.800B $1.919B
Total Liabilities $7.376B $6.835B
YoY Change -52.03% 12.45%
SHAREHOLDERS EQUITY
Retained Earnings $1.639B $1.314B
YoY Change -967.2% -392.0%
Common Stock $20.82B $20.73B
YoY Change 1.77% 1.75%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.251B $2.251B
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $20.37B $19.93B
YoY Change
Total Liabilities & Shareholders Equity $37.11B $36.67B
YoY Change 10.44% 11.48%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $324.0M $493.0M
YoY Change 24.14% 64.33%
Depreciation, Depletion And Amortization $213.0M $304.0M
YoY Change -28.52% 49.75%
Cash From Operating Activities $813.0M $164.0M
YoY Change 23.74% -13.68%
INVESTING ACTIVITIES
Capital Expenditures $155.0M $179.0M
YoY Change 8.39% 61.26%
Acquisitions $47.00M
YoY Change -87.47%
Other Investing Activities -$116.0M -$7.000M
YoY Change -83.36% -22.22%
Cash From Investing Activities -$271.0M -$285.0M
YoY Change -67.74% -41.12%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change -100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 24.00M $1.569B
YoY Change -44.19% -2373.91%
NET CHANGE
Cash From Operating Activities 813.0M $164.0M
Cash From Investing Activities -271.0M -$285.0M
Cash From Financing Activities 24.00M $1.569B
Net Change In Cash 566.0M $1.441B
YoY Change -504.29% -496.97%
FREE CASH FLOW
Cash From Operating Activities $813.0M $164.0M
Capital Expenditures $155.0M $179.0M
Free Cash Flow $658.0M -$15.00M
YoY Change 28.02% -118.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1209000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1040000000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
2648000000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
2349000000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1364000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1215000000 usd
CY2024Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
366000000 usd
CY2023Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
337000000 usd
CY2024Q1 us-gaap Royalty Expense
RoyaltyExpense
10000000 usd
CY2023Q1 us-gaap Royalty Expense
RoyaltyExpense
11000000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
214000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
203000000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
17000000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12000000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
3000000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
20000000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1973000000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1797000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
675000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
552000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
69000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
65000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-43000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
608000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
444000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
115000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
131000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
493000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
314000000 usd
CY2024Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2023Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
14000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
495000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
300000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1468400000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1435800000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1481700000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1446000000 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
493000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
314000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
57000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-42000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
22000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-43000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
5000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
78000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-91000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
572000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
223000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest
-6000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest
0 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
578000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
223000000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1729000224 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
17000000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
17000000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
263289848 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
263289848 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2251000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2329000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
865000000 usd
CY2024Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
2304000000 usd
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
2228000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
2561000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2484000000 usd
CY2024Q1 us-gaap Prepaid Taxes
PrepaidTaxes
319000000 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
315000000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
671000000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
621000000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
8185000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6514000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2897000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2859000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
14361000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
14387000000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5839000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6003000000 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3792000000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3841000000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1596000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1531000000 usd
CY2024Q1 us-gaap Assets
Assets
36669000000 usd
CY2023Q4 us-gaap Assets
Assets
35136000000 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
1085000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
531000000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
921000000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
942000000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2083000000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2646000000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
827000000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
814000000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4916000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4933000000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
9534000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
8571000000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
132000000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
134000000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1919000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1967000000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2251000000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20713000000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20647000000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1314000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
819000000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
132000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
49000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
19926000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
19282000000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
242000000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
248000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20168000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19530000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36669000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35136000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
19926000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
17850000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20168000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
18109000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
493000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
314000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
304000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
285000000 usd
CY2024Q1 bsx Cash Flow Impact Of Deferred Income Tax Expense Benefit
CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
31000000 usd
CY2023Q1 bsx Cash Flow Impact Of Deferred Income Tax Expense Benefit
CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
19000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
63000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
55000000 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-2000000 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-31000000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
17000000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12000000 usd
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-4000000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-2000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
114000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
86000000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
124000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
185000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
55000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
41000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-450000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-211000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
164000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
190000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
179000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
111000000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
47000000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
375000000 usd
CY2024Q1 bsx Proceeds From Payments For Investments And Acquisitions Of Certain Technologies
ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies
66000000 usd
CY2023Q1 bsx Proceeds From Payments For Investments And Acquisitions Of Certain Technologies
ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies
10000000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-7000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-9000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-285000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-484000000 usd
CY2024Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
34000000 usd
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
34000000 usd
CY2024Q1 bsx Payments For Royalty Rights
PaymentsForRoyaltyRights
15000000 usd
CY2023Q1 bsx Payments For Royalty Rights
PaymentsForRoyaltyRights
34000000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
25000000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
CY2024Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
504000000 usd
CY2023Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
2145000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
14000000 usd
CY2024Q1 bsx Paymenttonetsharesettleemployeeequityawards
Paymenttonetsharesettleemployeeequityawards
78000000 usd
CY2023Q1 bsx Paymenttonetsharesettleemployeeequityawards
Paymenttonetsharesettleemployeeequityawards
50000000 usd
CY2024Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
80000000 usd
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
63000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1569000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-69000000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1441000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-363000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1055000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1126000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2496000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
763000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
63000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
55000000 usd
CY2024Q1 bsx Noncashimpactoftransferredroyaltyrights
Noncashimpactoftransferredroyaltyrights
-7000000 usd
CY2023Q1 bsx Noncashimpactoftransferredroyaltyrights
Noncashimpactoftransferredroyaltyrights
-9000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2329000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
570000000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
93000000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
135000000 usd
CY2024Q1 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
74000000 usd
CY2023Q1 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
57000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2496000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
763000000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
404000000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
17000000 usd
CY2024Q1 bsx Payment Of Contingent Consideration
PaymentOfContingentConsideration
148000000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
273000000 usd
CY2024Q1 bsx Uncapped Contingent Considertation
UncappedContingentConsidertation
164000000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
211000000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
219000000 usd
CY2024Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
218000000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
194000000 usd
CY2024Q1 us-gaap Investments
Investments
429000000 usd
CY2023Q4 us-gaap Investments
Investments
413000000 usd
CY2024Q1 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
237000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15863000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10198000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15817000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9988000000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
174000000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
174000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
14387000000 usd
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
24000000 usd
CY2024Q1 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-51000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
14361000000 usd
CY2024Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
6954000000 usd
CY2023Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
6896000000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1209000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
69000000 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
69000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1040000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
65000000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
43000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
65000000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
302000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
266000000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
986000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1050000000 usd
CY2024Q1 us-gaap Cash
Cash
384000000 usd
CY2023Q4 us-gaap Cash
Cash
411000000 usd
CY2024Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
10224000000 usd
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
8735000000 usd
CY2024Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
10619000000 usd
CY2023Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
9102000000 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
1085000000.000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
531000000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
9534000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
8571000000 usd
CY2024Q1 bsx Qualified Acquisition Consideration
QualifiedAcquisitionConsideration
1000000000 usd
CY2024Q1 bsx Amount Excluded From Debt In Leverage Ratio
AmountExcludedFromDebtInLeverageRatio
2138000000 usd
CY2024Q1 bsx Exclusion From Ebitda For Restructuring Charges
ExclusionFromEbitdaForRestructuringCharges
500000000 usd
CY2024Q1 bsx Restructuring Charges Remaining To Be Excluded From Calculation Of Consolidated Ebitda
RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
273000000 usd
CY2024Q1 bsx Litigation Payment Exclusion From Ebitda
LitigationPaymentExclusionFromEBITDA
1000000000 usd
CY2024Q1 bsx Legal Payments Remaining To Be Excluded From Calculation Of Consolidated Ebitda
LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
1457000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
2145000000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
174000000 usd
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
174000000 usd
CY2024Q1 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
140000000 usd
CY2023Q4 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
152000000 usd
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2413000000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2338000000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
109000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
110000000 usd
CY2024Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
2304000000 usd
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
2228000000 usd
CY2023Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
110000000 usd
CY2022Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
109000000 usd
CY2024Q1 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
9000000 usd
CY2023Q1 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
16000000 usd
CY2024Q1 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
10000000 usd
CY2023Q1 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
6000000 usd
CY2024Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
109000000 usd
CY2023Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
118000000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1555000000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1537000000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
188000000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
174000000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
818000000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
773000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
2561000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2484000000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
93000000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
130000000 usd
CY2024Q1 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
177000000 usd
CY2023Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
159000000 usd
CY2024Q1 bsx Licensingarrangements
Licensingarrangements
44000000 usd
CY2023Q4 bsx Licensingarrangements
Licensingarrangements
47000000 usd
CY2024Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
357000000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
285000000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
671000000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
621000000 usd
CY2024Q1 us-gaap Land
Land
141000000 usd
CY2023Q4 us-gaap Land
Land
140000000 usd
CY2024Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1856000000 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1843000000 usd
CY2024Q1 bsx Equipment Furniture And Fixtures Gross
EquipmentFurnitureAndFixturesGross
3550000000 usd
CY2023Q4 bsx Equipment Furniture And Fixtures Gross
EquipmentFurnitureAndFixturesGross
3503000000 usd
CY2024Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
880000000 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
857000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6427000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6343000000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3530000000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3484000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2897000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2859000000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
90000000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
82000000 usd
CY2024Q1 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
74000000 usd
CY2023Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
60000000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
430000000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
439000000 usd
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
125000000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
107000000 usd
CY2024Q1 us-gaap Investments
Investments
429000000 usd
CY2023Q4 us-gaap Investments
Investments
413000000 usd
CY2024Q1 bsx Licensingarrangementsasset
Licensingarrangementsasset
22000000 usd
CY2023Q4 bsx Licensingarrangementsasset
Licensingarrangementsasset
30000000 usd
CY2024Q1 bsx Indemnification Asset
IndemnificationAsset
175000000 usd
CY2023Q4 bsx Indemnification Asset
IndemnificationAsset
176000000 usd
CY2024Q1 bsx Other Other Longterm Assets
OtherOtherLongtermAssets
341000000 usd
CY2023Q4 bsx Other Other Longterm Assets
OtherOtherLongtermAssets
306000000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1596000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1531000000 usd
CY2024Q1 us-gaap Litigation Reserve Current
LitigationReserveCurrent
129000000 usd
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
206000000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
749000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1051000000 usd
CY2024Q1 bsx Accrued Rebates Current
AccruedRebatesCurrent
384000000 usd
CY2023Q4 bsx Accrued Rebates Current
AccruedRebatesCurrent
389000000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
182000000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
304000000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
639000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
696000000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2083000000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2646000000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
280000000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
266000000 usd
CY2024Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
45000000 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
49000000 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
257000000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
220000000 usd
CY2024Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
246000000 usd
CY2023Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
278000000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
827000000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
814000000 usd
CY2024Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
466000000 usd
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
470000000 usd
CY2024Q1 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
154000000 usd
CY2023Q4 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
172000000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
90000000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
100000000 usd
CY2024Q1 bsx Licensingarrangementsliability
Licensingarrangementsliability
26000000 usd
CY2023Q4 bsx Licensingarrangementsliability
Licensingarrangementsliability
41000000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
382000000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
390000000 usd
CY2024Q1 us-gaap Deferred Revenue
DeferredRevenue
314000000 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
311000000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
486000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
484000000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1919000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1967000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.189
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.294
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
465000000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
393000000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
467000000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
395000000 usd
CY2024Q1 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
11000000 usd
CY2024Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
283000000 usd
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
377000000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
93000000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
130000000 usd
CY2023Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
42000000 usd
CY2024Q1 bsx Brazil Cade Of Individuals For Alleged Anti Competitive Behavior
BrazilCADEOfIndividualsForAllegedAntiCompetitiveBehavior
29 units
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1468400000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1435800000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13400000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10200000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1481700000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1446000000 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
4000000000000 shares
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 reportablesegments
CY2024Q1 bsx Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
29000000 usd
CY2023Q1 bsx Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
52000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3856000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3389000000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
214000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
203000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
675000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
552000000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-67000000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-108000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
608000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
444000000 usd
CY2024Q1 bsx Number Of Businesses
NumberOfBusinesses
5 business
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3856000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3389000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3856000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3389000000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
593000000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
577000000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
62000000 usd

Files In Submission

Name View Source Status
0000885725-24-000046-index-headers.html Edgar Link pending
0000885725-24-000046-index.html Edgar Link pending
0000885725-24-000046.txt Edgar Link pending
0000885725-24-000046-xbrl.zip Edgar Link pending
bsx-20240331.htm Edgar Link pending
bsx-20240331.xsd Edgar Link pending
exhibit101-bscx2024grantxn.htm Edgar Link pending
exhibit102-bscx2024grantxr.htm Edgar Link pending
exhibit103-bscx2024grantxt.htm Edgar Link pending
exhibit104-bscx2024grantxo.htm Edgar Link pending
exhibit22-subsidiaryissuer.htm Edgar Link pending
exhibit311-ceo302q12024.htm Edgar Link pending
exhibit312-cfo302q12024.htm Edgar Link pending
exhibit321-ceo906q12024.htm Edgar Link pending
exhibit322-cfo906q12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
image_0a.jpg Edgar Link pending
image_1.jpg Edgar Link pending
image_2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
bsx-20240331_cal.xml Edgar Link unprocessable
bsx-20240331_def.xml Edgar Link unprocessable
bsx-20240331_lab.xml Edgar Link unprocessable
bsx-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bsx-20240331_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending